New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
10:01 EDTICE, BOCH, MLNX, HLF, RIMM, GG, FOLD, KBH, DFS, DAR, NKE, ELOQ, NYX, MDRX, TCRDOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Amicus Theraputics (FOLD) downgraded to Underperform from Neutral at Wedbush... Bank of Commerce Holdings (BOCH) downgraded to Market Perform at Raymond James... Eloqua (ELOQ) downgraded to Neutral from Overweight at JPMorgan... Goldcorp (GG) downgraded to Neutral from Outperform at Credit Suisse... IntercontinentalExchange (ICE) downgraded to Market Perform at Bernstein... Nike (NKE) downgraded to Neutral from Buy at Janney Capital... Research in Motion (RIMM) downgraded to Sell from Underperform at CLSA... THL Credit (TCRD) downgraded to Hold from Buy at Deutsche Bank... Darling (DAR) downgraded to Equal Weight from Overweight at Stephens... Herbalife (HLF) downgraded to Hold from Buy at Argus... Allscripts (MDRX) downgraded to Hold from Buy at Argus... Discover (DFS) downgraded to Market Perform from Outperform at FBR Capital... Mellanox (MLNX) downgraded to Hold from Buy at Maxim... NYSE Euronext (NYX) downgraded to Market Perform from Outperform at Keefe Bruyette... KB Home (KBH) downgraded to Sell from Hold at Williams Capital.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 >>
September 24, 2015
13:27 EDTNKENike September 114 weekly straddle priced for 4.2% movement into Q1
Subscribe for More Information
12:32 EDTNKEEarnings Watch: Analysts positive on Nike ahead of Q1 earnings report
Nike (NKE) is expected to report first quarter earnings after the bell on Thursday, September 24, with a conference call scheduled for 5:00 pm ET. Nike sells athletic footwear, apparel, equipment and accessories worldwide. EXPECTATIONS: Analysts are looking for earnings per share of $1.19 on revenue of $8.22B. The consensus range is $1.14-$1.26 for EPS and $8.13B-$8.33B for revenue. In its last earnings report, Nike forecast Q1 revenue growth in the low single digits. LAST QUARTER: The company reported fourth quarter EPS of 98c and revenue of $7.8B, beating the consensus expectation of 83c and $7.69B, respectively. Nike reported a Q4 gross margin of 46.2%, which was up 60 basis points. The company also reported worldwide futures orders up 2% including currency changes and up 13% excluding currency changes. Looking ahead, Nike forecast fiscal year 2016 revenue growth in the mid-single digits, and said it expected Q1 and FY16 gross margin to increase by 50bps. On its last earnings conference call, Nike said it was confident that it would be able to keep "moving margins forward." The company said it plans to deliver mid-teens EPS growth over time. NEWS: Phil Knight announced plans to step down as the company's chairman on June 30, and recommended president and Chief Executive Officer Mark Parker take over the role. Knight said he would transfer most of his stock to a limited liability company named Swoosh LLC, to be managed by himself, Parker and other Nike executives. The move that will help "maintain Nike's corporate governance," the company said. Under terms agreed upon in June, Nike will pay $2.4M to customers who purchased a FuelBand product anytime between January 19, 2012 and June 17, 2015 to settle a class action suit leveled against itself and Apple (AAPL) in 2013, AppleInsider reported in July. STREET RESEARCH: On the day after its last earnings report, Nike's price target was raised at Piper Jaffray, Nomura, Macquarie, Goldman, Deustche Bank and Baird. On July 28, Jefferies raised its price target for Nike to $128 to reflect greater likelihood of the Trans-Pacific Partnership becoming law, which could benefit Nike's margins over time. In August, Telsey Advisory upgraded Nike to Outperform from Market Perform and Susquehanna upgraded shares to Positive from Neutral. Stifel said on August 27 that Nike "continues to dominate" in all areas of footwear and predicted that Nike's revenue could increase by low single digits in FY16. Ahead of this afternoon's earnings report, Deutsche Bank, Susquehanna and UBS raised their price targets on Nike. Deutsche Bank expects Nike to post "modest" Q1 upside today. PRICE ACTION: Over the last three months, Nike shares are up about 7.15%. Ahead of this afternoon's report, shares are down 1.2% to $114.16.
12:02 EDTKBHKB Home says may have 'slight' sequential decline in year-end community count
Subscribe for More Information
11:58 EDTKBHKB Home sees 2015 average community count expansion in excess of 20% vs. 2014
Subscribe for More Information
11:54 EDTKBHKB Home sees Q4 housing revenue $1.04B-$1.1B
Says in "active" negotiations on additional land sales, but doesn't see closing any deals in Q4. Sees housing gross profit margin increasing sequentially in Q4. Still sees housing gross profit margin in excess of 18% in Q4. Sees Q1 housing gross profit margin in mid 16% range
11:50 EDTKBHKB Home says entering Q4 from 'position of strength'
Subscribe for More Information
10:01 EDTMLNXOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:32 EDTKBHKB Home: Q3 results showed broad-based improvement in virtually all metrics
"Our third quarter results showed broad-based improvement in virtually all key operational and financial metrics across our four regions," said Jeffrey Mezger, president and CEO. "In particular, we achieved appreciable growth in homes delivered, revenues and pretax earnings in the third quarter largely through the execution of our core strategies. This performance reflects our measurably expanded community count and success in converting the robust backlog we built during the first half of this year into deliveries. Moving forward, we remain focused on improving profitability by expanding our housing gross profit margin and increasing operating leverage as we continue to build up the scale of our business. Based on the progress we have made on our strategic priorities, our significantly higher backlog, and the continued improvement in housing market fundamentals, we are anticipating a strong finish to the year. Furthermore, we expect to maintain this momentum into 2016."
08:31 EDTKBHKB Home reports Q3 EPS 23c, consensus 22c
Reports Q3 revenue $843.2M, consensus $818.53M. Housing revenues increased 36% to $798.6 million from $586.2 million for the corresponding period of 2014, reflecting greater delivery volume and a higher overall average selling price. The Company delivered 2,236 homes, up 25% from 1,793 homes in the year-earlier quarter. The overall average selling price rose 9% to $357,200, compared to $327,000 a year ago, as average selling prices increased in each of the Company's four regions. Land sale revenues totaled $41.6 million, reflecting activity in the Company's West Coast, Southwest and Southeast regions. There were no land sales in the year-earlier period. Potential future housing revenues in backlog grew 44% to $1.59 billion at August 31, 2015, from $1.10 billion at August 31, 2014, reflecting substantial year-over-year increases in each of the Company's four regions. Net orders grew 19% to 2,167 for the quarter, compared to 1,827 in the year-earlier quarter. The cancellation rate as a percentage of gross orders of 30% was nearly even with the third quarter of 2014, and as a percentage of beginning backlog was 20% versus 24% a year ago. The Company's overall average community count for the third quarter increased 30% to 257 from 197 for the year-earlier quarter.
06:50 EDTDFSAmerican Express price target lowered to $70 from $85 at Jefferies
Jefferies analyst John Hecht says that even with the recent selloff, shares of American Express do not offer "compelling rewards" at current levels. Hecht believes AmEx is nearing saturation in its core demographic, the highly-affluent consumer, and views the Costco (COST) loss as a "significant challenge to overcome." American Express remains the industry leader in terms of rewards, but the gap to competitors has narrowed, Hecht tells investors in a research note. The company faces "several discrete headwinds" over the coming quarters, the analyst concludes. He cut his price target for AmEx shares to $70 from $85 and keeps a Hold rating on the name. The credit card provider closed yesterday down 8c to $75.63. Hecht has Buy ratings on card peers Discover (DFS) and Synchrony Financial (SYF).
06:32 EDTMLNXMellanox initiated with a Buy at DA Davidson
Subscribe for More Information
September 23, 2015
15:02 EDTKBHNotable companies reporting before tomorrow's open
Subscribe for More Information
14:41 EDTKBHKB Home volatility elevated into Q3 and outlook
KB Home October call option implied volatility is at 51, November is at 44; compared to its 52-week range of 25 to 53, suggesting large near term price movement into the expected release of Q3 results on September 24.
07:34 EDTNKENike shares have room for further upside, says Deutsche Bank
Deutsche Bank analyst Dave Weiner says that despite the 20% year-to-date rally, shares of Nike have room for further upside. Nike's business in China is accelerating and operating margin strength should continue, Weiner tells investors in a research note. The analyst expects Nike to post "modest" Q1 upside when reporting results tomorrow after the close. He keeps a Buy rating on the stock with a $125 price target.
07:18 EDTMDRXAllscripts management to meet with Deutsche Bank
Meeting to be held in San Francisco on September 23 hosted by Deutsche Bank.
September 22, 2015
07:34 EDTGG, ICEDenver Gold Group to hold a forum
Subscribe for More Information
06:43 EDTNKENike September weekly volatility elevated into Q1 and outlook
Subscribe for More Information
September 21, 2015
13:17 EDTFOLDRBC reminds biotech investors that Republicans still control Congress
RBC Capital analyst Michael Yee notes that biotech indices are under pressure after Hillary Clinton tweeted about an upcoming plan to fight specialty drug pricing. The news follows a Wall Street Journal story about a private company dramatically increasing the price of their drug and another confirmed progressive multifocal leukoencephalopathy case for Biogen (BIIB), Yee tells investors in an intraday research note. Next year's election is likely to turn up the noise around drug pricing, creating headline risk for the biotech space, the analyst cautions. However, he reminds investors that Republicans control Congress, making it unlikely that "anything material" will get signed into law. Biotech names moving lower in today's trading include Biogen, AbbVie (ABBV), Gilead (GILD), Alkermes (ALKS), BioMarin (BMRN), Amicus (FOLD) and PTC Therapeutics (PTCT).
07:42 EDTNKENike price target raised to $128 from $122 at UBS
Subscribe for More Information
September 20, 2015
15:38 EDTGGTimmins to acquire plant from El Sauzal mine, Goldcorp to invest in Timmins
Subscribe for More Information
1 | 2 | 3 | 4 | 5 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use